FAAH and migraine disorder: In a later study utilizing the same model, administration of the FAAH inhibitor URB597 before NTG administration significantly elevated levels of both AEA and PEA in the medulla, cervical spinal cord, and trigeminal ganglia, peripheral neural structures known to be involved in migraine pathology [67].